
Editor's letter
IFAs say the UK market is inundated with copycat products that possess about as much appeal as in-flight meals. A touch of creativity is urgently required if the market is finally to prosper

First, a word of warning: news that the UK market is contracting and the French market stagnating means this month's issue doesn't make for cheery summer reading.
In our cover story we look at how the UK market has shrunk for the fourth time in five years, and we also tell how Bristol & West, previously a market leader, has decided to exit the business. There seems to be suspicion on the part of independent financial advisers (IFAs) about structured products. Bravado by some UK distributors that say IFAs are advising clients to buy into structured products hides the reality that derivatives-based investments have failed to capture the imagination of IFAs or the investing public in quite the same way as they have on the Continent. In fact, IFAs say the UK market is inundated with copycat products that possess about as much appeal as in-flight meals. A touch of creativity is urgently required if the UK market is finally to prosper. Thankfully, it seems a few distributors are finally realising this, and we eagerly await news of more interesting bespoke products in the hope that other distributors don't go the same way as Bristol & West.
The French market is also suffering to a certain extent. Volumes may be up, but only just. Quite simply, more competition is required in a country that was previously famed for its structured products innovation. Investors are tired of the same old payoffs, but few companies are bothering to offer alternatives. Thankfully, Exane, for one, is bucking the trend and pushing commodity-linked products. And an amendment to French law - which lets investors convert their non-unit-linked life insurance contracts into a multi-investment policy without forfeiting tax benefits - could spur a whole host of innovative new offerings.
The lesson is that distributors and structurers must constantly explore new areas and react decisively to changing market conditions if structured products sales are to grow.
But which structurers are best placed to deliver innovation? You have the chance to tell us who you rate in our inaugural European survey. Look out for details of our monthly polls, starting in August.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@risk.net
More on Regulation
The VAR-centric models that never were
Often spotlighted, rarely dominant – VAR plays a surprisingly small role in most IMA stacks
European supervisors showing ‘no mercy’ on SA-CVA approvals
Risk Live Europe: Bank of America found the compliance workload similar to FRTB internal models
Regulators urged to use Dora reporting to track systemic risk
Risk Live: Bankers and regulator say governance requirements for new rules are complex to implement
BoE official plays down fears of global regulatory fragmentation
Risk Live: UK expects close co-operation with US, while others express concern over Basel III endgame
Barclays takes selective approach to FRTB IMA applications
Risk Live: UK bank is applying for approval for parts of its portfolio most likely to pass approval tests
US Basel III delay to 2026 seen as almost inevitable
Reprioritisation and leadership changes cast doubts on timing of new proposals
EU tipped to tag less than 30 tech firms as critical for Dora
Irish regulator suggests European supervisors will take narrower view than some feared
Trading venues seen as easiest targets for Esma supervision
Platforms do not pose systemic risks for member states and are already subject to consistent rules